Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment

• Federico Angriman,
• Maria Nelly Gutierrez Acevedo,
• Maria Sol Rossi,
• Alberto Daniel Gimenez Conca,
• Victoria Otero,
• Jorge Alberto Arbelbide,
• Hernán Michelángelo

Affiliations

Federico Angriman

Buenos Aires University School of Medicine, Hospital Italiano de Buenos Aires, Department of Internal Medicine, Buenos Aires, Argentina

Maria Nelly Gutierrez Acevedo

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Buenos Aires, Argentina

Maria Sol Rossi

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Buenos Aires, Argentina

Alberto Daniel Gimenez Conca

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Division of Hematology, Buenos Aires, Argentina

Victoria Otero

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Division of Hematology, Buenos Aires, Argentina

Jorge Alberto Arbelbide

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Division of Hematology, Buenos Aires, Argentina

Hernán Michelángelo

Hospital Italiano de Buenos Aires, Department of Internal Medicine, Buenos Aires, Argentina